Cargando…
Assessing CYP2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus Inhibition
The objective of this study was to develop pediatric physiologically based pharmacokinetic (PBPK) models for pantoprazole and esomeprazole. Pediatric PBPK models were developed by Simcyp version 15 by incorporating cytochrome P450 (CYP)2C19 maturation and auto‐inhibition. The predicted‐to‐observed p...
Autores principales: | Duan, Peng, Wu, Fang, Moore, Jason N., Fisher, Jeffrey, Crentsil, Victor, Gonzalez, Daniel, Zhang, Lei, Burckart, Gilbert J., Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430158/ https://www.ncbi.nlm.nih.gov/pubmed/30520273 http://dx.doi.org/10.1002/psp4.12350 |
Ejemplares similares
-
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
por: George, Blessy, et al.
Publicado: (2020) -
Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2015) -
Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding
por: Van der Veken, Matthias, et al.
Publicado: (2023) -
T cell ontogeny. Organ location of maturing populations as defined by surface antigen markers is similar in neonates and adults
Publicado: (1981) -
Ethanol Pharmacokinetics in Neonates and Infants
por: Marek, Elizabeth, et al.
Publicado: (2014)